HAYWARD, Calif., March 21, 2025 /PRNewswire/ — Accuryn Medical, a company dedicated to addressing acute kidney injury through real-time renal monitoring and assessment based on global clinical practice guidelines, today announced that Todd Dunn, Accuryn’s Chief Transformation Officer, will transition to a new role leading the company as Chief Executive Officer. Dunn succeeds Sanjay Banerjee, who is stepping down from his role as CEO.
Accuryn Medical Announces Leadership Transition With Appointment of Todd Dunn as CEO
